Evidence map›Paper›PMID 36289960›Full record

ArticleAntibiotics (Basel, Switzerland)2022

Optimized Chemical Extraction Methods of Antimicrobial Peptides from Roots and Leaves of Extremophilic Plants:

Raoua Ben Brahim, Hasna Ellouzi, Khaoula Fouzai, Nedra Asses, Mohammed Neffati, Jean Marc Sabatier, Philippe Bulet, Imed Regaya

Open access · goldAbstract read
In one paragraph

Article in Antibiotics (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Cliotide U1, a Novel Antimicrobial Peptide Isolated FromBioinformatics and biology insights · 2025
    Article
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 2 countries.

Raoua Ben BrahimLaboratory of Extremophile Plants, Centre of Biotechnology of Borj Cedria, B.P. 901, Hammam-Lif 2050, Tunisia.
Hasna EllouziLaboratory of Extremophile Plants, Centre of Biotechnology of Borj Cedria, B.P. 901, Hammam-Lif 2050, Tunisia.
Khaoula FouzaiLaboratory of Extremophile Plants, Centre of Biotechnology of Borj Cedria, B.P. 901, Hammam-Lif 2050, Tunisia.
Nedra AssesHigher Institute of Sciences and Technologies of the Environment of Borj Cedria, University of Carthage, Amilcar 1054, Tunisia.
Mohammed NeffatiLaboratory of Pastoral Ecosystems and Valorization of Spontaneous Plants, LR16IRA03, Institute of Arid Regions, University of Gabès, Médenine 4119, Tunisia.
Jean Marc SabatierInstitut de Neurophysiopathologie (INP), Faculté des Sciences Médicales et Paramédicales, Aix-Marseille Université, CNRS UMR 7051, 27 Bd Jean Moulin, 13005 Marseille, France.ORCID 0000-0002-9040-5647
Philippe BuletPlateform BioPark Archamps, 218 Avenue Marie Curie Archparc, 74160 Archamps, France.ORCID 0000-0001-9016-265X
Imed RegayaLaboratory of Extremophile Plants, Centre of Biotechnology of Borj Cedria, B.P. 901, Hammam-Lif 2050, Tunisia.
University of Carthage · TNCentre National de la Recherche Scientifique · FRCenter of Biotechnogy of Borj Cédria · TNUniversity of Gabès · TNUniversity of Monastir · TN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extraction methods depend mainly on the chemical nature of the extracted molecule. For these reasons, the selection of the extraction medium is a vital part of obtaining these molecules. The extraction of antimicrobial peptides (AMPs) from extremophile plants is important because of its potential pharmaceutical applications. This work focused on the evaluation of several solvents for the extraction of AMPs from the following two extremophile plants:

Indexed as

Anthyllis sericeaantimicrobial peptidesAstragalus armatusextraction solventExtremophile plantsoptimization

Identifiers

PMID36289960
PMCPMC9599020
OpenAlexW4297150898

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.